TU Dortmund is among the winners of North Rhine Westphalia’s Bio.NRW competition, taking €540,000 to develop new biocatalysis technologies.
Whole cell biocatalysis is an essential component in the development of industrial biotechnology. It can be applied for the production of complex and environmentally-friendly chemicals and pharmaceuticals, and cosmetics and food ingredients.
The central aim of the biocatalysis technology platform is to optimise the use of microbial metabolism in the synthesis of fine chemicals. The technology platform will be integrated into the North-Rhine-Westphalian cluster for industrial biotechnology, CLIB2021. The cluster features prominent chemicals companies such as Bayer, Cognis, Evonik, Henkel and Lanxess, alongside small and medium-scale enterprises.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.